Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Лекарственно-индуцированные гипогликемии: фокус на препараты, не относящиеся к группе сахароснижающих лекарственных средств
________________________________________________
Ostroumova O.D., Akimova E.S., Kochetkov A.I., Pereverzev A.P. Medically induced hypoglycemia: focus on medications not included in the group of antihyperglycemic medications. Consilium Medicum. 2019; 21 (4): 59–65. DOI: 10.26442/20751753.2019.4.190196
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Ключевые слова: гипогликемия, лекарственно-индуцированная гипогликемия, побочные эффекты лекарственных средств, пожилой и старческий возраст.
________________________________________________
Key words: hypoglycemia, drug-induced hypoglycemia, adverse drug reaction, older age.
[Dedov I.I., Shestakova M.V., Vikulova O.K. et al. Sakharnyi diabet v Rossiiskoi Federatsii: rasprostranennost', zabolevaemost', smertnost', parametry uglevodnogo obmena i struktura sakharosnizhaiushchei terapii po dannym Federal'nogo registra sakharnogo diabeta, status 2017 g. Sakharnyi diabet. 2018; 3 (21): 144–59. DOI: 10.14341/DM9686 (in Russian).]
2. Сычев Д.А. Полипрагмазия в клинической практике: проблема и решения. Учебное пособие для врачей. СПб., 2016.
[Sychev D.A. Polipragmaziia v klinicheskoi praktike: problema i resheniia. Uchebnoe posobie dlia vrachei. Saint Petersburg, 2016 (in Russian).]
3. Vue MH, Setter SM. Drug-Induced Glucose Alterations Part 1: Drug-Induced Hypoglycemia. Diabetes Spectrum 2011; 24 (3): 171–7. DOI: 10.2337
4. Pandit M, Burke J, Gustafson A et al. Drug-induced disorders of glucose tolerance. Ann Intern Med 1993; 7: 529–39.
5. Дедов И.И., Шестакова М.В., Майоров А.Ю. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. 8-й выпуск. Сахарный диабет. 2017; 20 (1S): 1–121.
[Dedov I.I., Shestakova M.V., Maiorov A.Iu. Algoritmy spetsializirovannoi meditsinskoi pomoshchi bol'nym sakharnym diabetom. 8-i vypusk. Sakharnyi diabet. 2017; 20 (1S): 1–121 (in Russian).]
6. Helms K, Kelley K. Drug-Induced Hypoglycemia, Hypoglycemia – Causes and Occurrences [online]. 2011; р. 113–30. http://cdn.intechopen.com/pdfswm/21469.pdf
7. Zammit NN, Frier BM. Hypoglycemia in type 2 diabetes. Pathophysiology, frequency, and effects of different treatment modalities. Diabetes Care 2005; 28 (12): 2948–61.
8. Murad M, Coto-Yglesias F, Wang A et al. Drug-induced hypoglycemia: a systematic review. J Clin Endocrinol Metab 2009; 94 (3): 741–5. DOI: 10,1210
9. Seltzer HS. Drug-induced hypoglycemia. A review of 1418 cases. Endocrinol Metab Clin North Am 1989; 18: 163–1833.
10. Ioannidis JP, Lau J. Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas. JAMA 2001; 285: 437–4434.
11. База данных неблагоприятных побочных реакций ВОЗ VigiBase. http://www.vigiaccess.org (Дата обращения: 17.12.2018).
[Baza dannykh neblagopriiatnykh pobochnykh reaktsii VOZ VigiBase. http://www.vigiaccess.org (Data obrashcheniia: 17.12.2018 (in Russian).]
12. Ferriere M, Lachkar H, Richard JL et al. Captopril and insulin sensitivity [letter]. Ann Intern Med 1985; 102: 134.
13. White J. The contribution of medications to hypoglycemia unawareness. Diabetes Spectrum 2007; 20 (2): 77–80.
14. White JR, Campbell RK. Dangerous and common drug interactions in patients with diabetes mellitus. Endocrinol Metab Clin North Am 2000; 29: 789–802.
15. White JR, Campbell RK. Drug-drug and drug-disease interactions and diabetes. Diabetes Educ 1995; 21: 283–9.
16. Product Information: InnoPran XL oral capsules, propranolol hydrochloride oral capsules. GlaxoSmithKline 2010.
17. Ma RCW, Kong APS, Chan N et al. Drug-induced endocrine and metabolic disorders. Drug Saf 2007; 30: 215–45.
18. Thomson Reuters Healthcare: Micromedex Healthcare Series. Greenwood Village, Colo., Thomson Reuters Healthcare, 2011. 11.12.2018. http://www.micromedex.com/products/hcs
19. Product Information: Pentam 300 IV, IM injection, pentamidine isethionate IV, IM injection. American Pharmaceutical Partners 2008.
20. Product Information: Nebupent inhalation solution, pentamidine isethionate inhalation solution. American Pharmaceutical Partners 2018.
21. Cryer PE, Axelrod L, Grossman AB et al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2009; 94: 709–28.
22. Maeda N, Tamagawa T, Niki I et al. Increase in insulin release by rat pancreatic islets by quinolone antibiotics. Br J Pharmacol 1996; 117: 372–6.
23. Frothingham R. Glucose homeostasis abnormalities associated with use of gatifloxacin. Clin Infect Dis 2005; 41(9): 1269–76.
24. Gajjar D, LaCreta F, Kollia G et al. Effect of multiple-dose gatifloxacin or ciprofloxacin on glucose homeostasis and insulin production in patients with noninsulin-dependent diabetes mellitus maintained with diet and exercise. Pharmacotherapy 2000; 20 (6): 76–86.
25. Park-Wyllie L, Juurlink D, Kopp A et al. Outpatient gatifloxacin therapy and dysglycemia in older adults. N Engl J Med 2006; 354 (25): 1352–61.
26. Product Information: Tequin oral tablets, injection, gatifloxacin oral tablets, injection. Bristol-Myers Squibb Company, 2011.
27. Greenberg AL, Decerbo M, Fan J. Gatifloxacin therapy associated with hypogly-cemia. Clin Infect Dis 2005; 40: 1210–1.
28. Goldfine AB, Fonseca V, Jablonski KA et al. The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Ann Intern Med 2005; 152: 346–57.
29. Hundal RS, Petersen KF, Mayerson AB et al. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest 2002; 109: 1321–6.
30. Product Information: Indocin intravenous injection, indomethacin intravenous injection. Lundbeck Inc, 2010.
31. Hosono S, Ohno T, Kimoto H et al. Reduction in blood glucose values following indomethacin therapy for patent ductus arteriosus. Pediatr Int 1999; 41 (5): 525–8.
32. Product Information: Qualaquin oral capsules, quinine sulfate oral capsules. AR Scientific Inc, 2010.
33. Field JB, Williams HE, Mortimore GE. Studies on the mechanism of ethanol-induced hypoglycemia. J Clin Invest 1962; 42 (4): 497–506.
34. Weathermon R, Crabb DW. Alcohol and medication interactions. Alcohol Res Health 1999; 23 (1): 40–54.
35. Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care 2003; 26 (3): 1902–12.
________________________________________________
1. Dedov I.I., Shestakova M.V., Vikulova O.K. et al. Sakharnyi diabet v Rossiiskoi Federatsii: rasprostranennost', zabolevaemost', smertnost', parametry uglevodnogo obmena i struktura sakharosnizhaiushchei terapii po dannym Federal'nogo registra sakharnogo diabeta, status 2017 g. Sakharnyi diabet. 2018; 3 (21): 144–59. DOI: 10.14341/DM9686 (in Russian).
2. Sychev D.A. Polipragmaziia v klinicheskoi praktike: problema i resheniia. Uchebnoe posobie dlia vrachei. Saint Petersburg, 2016 (in Russian).
3. Vue MH, Setter SM. Drug-Induced Glucose Alterations Part 1: Drug-Induced Hypoglycemia. Diabetes Spectrum 2011; 24 (3): 171–7. DOI: 10.2337
4. Pandit M, Burke J, Gustafson A et al. Drug-induced disorders of glucose tolerance. Ann Intern Med 1993; 7: 529–39.
5. Dedov I.I., Shestakova M.V., Maiorov A.Iu. Algoritmy spetsializirovannoi meditsinskoi pomoshchi bol'nym sakharnym diabetom. 8-i vypusk. Sakharnyi diabet. 2017; 20 (1S): 1–121 (in Russian).
6. Helms K, Kelley K. Drug-Induced Hypoglycemia, Hypoglycemia – Causes and Occurrences [online]. 2011; р. 113–30. http://cdn.intechopen.com/pdfswm/21469.pdf
7. Zammit NN, Frier BM. Hypoglycemia in type 2 diabetes. Pathophysiology, frequency, and effects of different treatment modalities. Diabetes Care 2005; 28 (12): 2948–61.
8. Murad M, Coto-Yglesias F, Wang A et al. Drug-induced hypoglycemia: a systematic review. J Clin Endocrinol Metab 2009; 94 (3): 741–5. DOI: 10,1210
9. Seltzer HS. Drug-induced hypoglycemia. A review of 1418 cases. Endocrinol Metab Clin North Am 1989; 18: 163–1833.
10. Ioannidis JP, Lau J. Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas. JAMA 2001; 285: 437–4434.
11. Baza dannykh neblagopriiatnykh pobochnykh reaktsii VOZ VigiBase. http://www.vigiaccess.org (Data obrashcheniia: 17.12.2018 (in Russian).
12. Ferriere M, Lachkar H, Richard JL et al. Captopril and insulin sensitivity [letter]. Ann Intern Med 1985; 102: 134.
13. White J. The contribution of medications to hypoglycemia unawareness. Diabetes Spectrum 2007; 20 (2): 77–80.
14. White JR, Campbell RK. Dangerous and common drug interactions in patients with diabetes mellitus. Endocrinol Metab Clin North Am 2000; 29: 789–802.
15. White JR, Campbell RK. Drug-drug and drug-disease interactions and diabetes. Diabetes Educ 1995; 21: 283–9.
16. Product Information: InnoPran XL oral capsules, propranolol hydrochloride oral capsules. GlaxoSmithKline 2010.
17. Ma RCW, Kong APS, Chan N et al. Drug-induced endocrine and metabolic disorders. Drug Saf 2007; 30: 215–45.
18. Thomson Reuters Healthcare: Micromedex Healthcare Series. Greenwood Village, Colo., Thomson Reuters Healthcare, 2011. 11.12.2018. http://www.micromedex.com/products/hcs
19. Product Information: Pentam 300 IV, IM injection, pentamidine isethionate IV, IM injection. American Pharmaceutical Partners 2008.
20. Product Information: Nebupent inhalation solution, pentamidine isethionate inhalation solution. American Pharmaceutical Partners 2018.
21. Cryer PE, Axelrod L, Grossman AB et al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2009; 94: 709–28.
22. Maeda N, Tamagawa T, Niki I et al. Increase in insulin release by rat pancreatic islets by quinolone antibiotics. Br J Pharmacol 1996; 117: 372–6.
23. Frothingham R. Glucose homeostasis abnormalities associated with use of gatifloxacin. Clin Infect Dis 2005; 41(9): 1269–76.
24. Gajjar D, LaCreta F, Kollia G et al. Effect of multiple-dose gatifloxacin or ciprofloxacin on glucose homeostasis and insulin production in patients with noninsulin-dependent diabetes mellitus maintained with diet and exercise. Pharmacotherapy 2000; 20 (6): 76–86.
25. Park-Wyllie L, Juurlink D, Kopp A et al. Outpatient gatifloxacin therapy and dysglycemia in older adults. N Engl J Med 2006; 354 (25): 1352–61.
26. Product Information: Tequin oral tablets, injection, gatifloxacin oral tablets, injection. Bristol-Myers Squibb Company, 2011.
27. Greenberg AL, Decerbo M, Fan J. Gatifloxacin therapy associated with hypogly-cemia. Clin Infect Dis 2005; 40: 1210–1.
28. Goldfine AB, Fonseca V, Jablonski KA et al. The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Ann Intern Med 2005; 152: 346–57.
29. Hundal RS, Petersen KF, Mayerson AB et al. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest 2002; 109: 1321–6.
30. Product Information: Indocin intravenous injection, indomethacin intravenous injection. Lundbeck Inc, 2010.
31. Hosono S, Ohno T, Kimoto H et al. Reduction in blood glucose values following indomethacin therapy for patent ductus arteriosus. Pediatr Int 1999; 41 (5): 525–8.
32. Product Information: Qualaquin oral capsules, quinine sulfate oral capsules. AR Scientific Inc, 2010.
33. Field JB, Williams HE, Mortimore GE. Studies on the mechanism of ethanol-induced hypoglycemia. J Clin Invest 1962; 42 (4): 497–506.
34. Weathermon R, Crabb DW. Alcohol and medication interactions. Alcohol Res Health 1999; 23 (1): 40–54.
35. Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care 2003; 26 (3): 1902–12.
1 ОСП «Российский геронтологический научно-клинический центр» – ФГБОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И.Пирогова» Минздрава России, Москва, Россия;
*ostroumova.olga@mail.ru
________________________________________________
1 Russian Clinical and Research Center of Gerontology – Pirogov Russian National Research Medical University, Moscow, Russia;
*ostroumova.olga@mail.ru